Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: Lack of correlation with metastasis to axillary lymph nodes

被引:28
作者
Kelly, LM
Buggy, Y
Hill, A
O'Donovan, N
Duggan, C
McDermott, EW
O'Higgins, NJ
Young, L
Duffy, MJ
机构
[1] St Vincents Univ Hosp, Dept Surg Med Oncol & Nucl Med, Dublin, Ireland
[2] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland
关键词
metastasis suppressor gene; BRMS1; human breast cancer;
D O I
10.1159/000086955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The BRMS1 ( breast cancer metastasis suppressor 1) gene has been found to suppress metastasis in animal models without inhibiting primary tumor growth. The aim of this study was to measure expression of BRMS1 mRNA in a panel of human breast carcinomas and compare its expression with parameters of local dissemination such as tumor size and lymph node metastasis. We also compared expression of BRMS1 mRNA in normal breast tissue, fibroadenomas, primary breast cancers and axillary nodal metastases from primary breast cancers. BRMS1 mRNA was detected in 10/11 (90%) specimens of normal breast tissue, 12/16 (75%) fibroadenomas, 64/82 (78%) primary breast cancer and 11/15 (64%) lymph node metastases ( p, NS). In the primary cancer, expression was independent of tumor size, tumor grade, metastasis to axillary nodes and hormone receptor status. Furthermore, similar levels of BRMS1 were found in normal breast tissue, primary breast carcinomas and lymph node metastases from primary breast cancer. Our results do not suggest a role for BRMS1 in suppressing metastasis to local lymph nodes in patients with breast cancer. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 15 条
[1]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[2]   Discordant protein and mRNA expression in lung adenocarcinomas [J].
Chen, GA ;
Gharib, TG ;
Huang, CC ;
Taylor, JMG ;
Misek, DE ;
Kardia, SLR ;
Giordano, TJ ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, SM ;
Beer, DG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (04) :304-313
[3]   Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells [J].
Cicek, M ;
Samant, RS ;
Kinter, M ;
Welch, DR ;
Casey, G .
CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (02) :149-157
[4]   Studies on oestrogen receptor-α and -β mRNA in breast cancer [J].
Cullen, R ;
Maguire, TM ;
McDermott, EW ;
Hill, ADK ;
O'Higgins, NJ ;
Duffy, MJ .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (09) :1118-1122
[5]   The urokinase plasminogen activator system: Role in malignancy [J].
Duffy, MJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) :39-49
[6]  
Duffy MJ, 2002, CLIN CHEM, V48, P1194
[7]   The biochemistry of metastasis [J].
Duffy, MJ .
ADVANCES IN CLINICAL CHEMISTRY, VOL 32, 1996, 32 :135-166
[8]  
Duffy MJ, 1996, CLIN CANCER RES, V2, P613
[9]   Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 [J].
Jänicke, F ;
Prechtl, A ;
Thomssen, C ;
Harbeck, N ;
Meisner, C ;
Untch, M ;
Sweep, CGJF ;
Selbmann, HK ;
Graeff, H ;
Schmitt, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :913-920
[10]   Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients [J].
Look, M ;
van Putten, W ;
Duffy, M ;
Harbeck, N ;
Christensen, IJ ;
Thomssen, C ;
Kates, R ;
Spyratos, F ;
Fernö, M ;
Eppenberger-Castori, S ;
Sweep, CGJF ;
Ulm, K ;
Peyrat, JP ;
Martin, PM ;
Magdelenat, H ;
Brünner, N ;
Duggan, C ;
Lisboa, BW ;
Bendah, PO ;
Quillien, V ;
Daver, A ;
Ricolleau, G ;
Meijer-Van Gelder, M ;
Manders, P ;
Fiets, WE ;
Blankenstein, M ;
Broët, P ;
Romain, S ;
Daxenbichler, G ;
Windbichler, G ;
Cufer, T ;
Borstnar, S ;
Kueng, W ;
Beex, L ;
Klijn, J ;
O'Higgins, N ;
Eppenberger, U ;
Jänicke, F ;
Schmitt, M ;
Foekens, J .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (03) :538-548